Caricamento...

Cost-effectiveness of bortezomib for multiple myeloma: a systematic review

OBJECTIVES: To review published cost-effectiveness analyses (CEA) assessing bortezomib (BTZ) for multiple myeloma (MM) and explore possible bias affecting the cost-effectiveness of BTZ. METHODS: Literature was searched for published CEAs assessing BTZ or BTZ-containing regimens for MM from 2003 to 2...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clinicoecon Outcomes Res
Autori principali: Chen, Wendong, Yang, Yicheng, Chen, Yi, Du, Fen, Zhan, Huan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4861606/
https://ncbi.nlm.nih.gov/pubmed/27217786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S104195
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !